Literature DB >> 18052952

Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine.

Vlasta Vuković1, Davor Plavec, Ivana Galinović, Arijana Lovrencić-Huzjan, Mislav Budisić, Vida Demarin.   

Abstract

OBJECTIVE: The aim of this study was to determine the lifetime prevalence of vertigo and dizziness in patients with migraine as compared with controls and to establish the lifetime prevalence of migrainous vertigo.
BACKGROUND: Dizziness and vertigo are relatively frequent complaints in general population; however, the prevalence of migrainous vertigo has not been extensively studied so far.
METHODS: The study included 327 migraine patients and 324 controls who do not suffer from frequent headaches. The study and control group were assessed clinically and through diagnostic workup for having vertigo, dizziness, hypotension, and sideropenic anemia.
RESULTS: Vertigo or dizziness was experienced by 51.7% of migraine patients (MVL group) and 31.5% in the control group (CVL group), P < .0001. Among the MVL group, 23.2% of patients met the criteria for migrainous vertigo. There was no difference between the MVL group and CVL group in frequency of attacks or the pattern of symptom appearance in relation to head movement. Patients in the MVL group more frequently had hypotension, P = .011. Patients with migraine with aura significantly more often had migraine attacks in association with vertigo or dizziness, P < .0001.
CONCLUSION: The lifetime prevalence of migrainous vertigo is relatively frequent in migraine patients, especially in migraine with aura.

Entities:  

Mesh:

Year:  2007        PMID: 18052952     DOI: 10.1111/j.1526-4610.2007.00939.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  32 in total

Review 1.  Vestibular Migraine in Children and Adolescents.

Authors:  Thyra Langhagen; Mirjam N Landgraf; Doreen Huppert; Florian Heinen; Klaus Jahn
Journal:  Curr Pain Headache Rep       Date:  2016-12

2.  Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects.

Authors:  Roberto Teggi; Bruno Colombo; Roberto Albera; Giacinto Asprella Libonati; Cristiano Balzanelli; Angel Batuecas Caletrio; Augusto P Casani; Juan Manuel Espinosa-Sanchez; Paolo Gamba; Jose A Lopez-Escamez; Sergio Lucisano; Marco Mandalà; Giampiero Neri; Daniele Nuti; Rudi Pecci; Antonio Russo; Eduardo Martin-Sanz; Ricardo Sanz; Gioacchino Tedeschi; Paola Torelli; Paolo Vannucchi; Giancarlo Comi; Mario Bussi
Journal:  Front Neurol       Date:  2018-06-05       Impact factor: 4.003

Review 3.  Vestibular migraine: who is the patient?

Authors:  Bruno Colombo; Roberto Teggi
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

4.  Management of vestibular migraine.

Authors:  Alexandre R Bisdorff
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

5.  Potential solutions to several vestibular challenges facing clinicians.

Authors:  Daniel M Merfeld; Adrian Priesol; Daniel Lee; Richard F Lewis
Journal:  J Vestib Res       Date:  2010       Impact factor: 2.435

6.  Headaches related to triptans therapy in patients of migrainous vertigo.

Authors:  Sanjay Prakash; Bhavana V Chavda; Hiren Mandalia; Rishi Dhawan; Deepak Padmanabhan
Journal:  J Headache Pain       Date:  2008-04-22       Impact factor: 7.277

Review 7.  Epidemiology of vertigo, migraine and vestibular migraine.

Authors:  Thomas Lempert; Hannelore Neuhauser
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

8.  Association Between Vestibular Migraine and Migraine Headache: Yet to Explore.

Authors:  Mehdi Abouzari; Khodayar Goshtasbi; Omid Moshtaghi; Donald Tan; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2020-03       Impact factor: 2.311

Review 9.  Current Treatment Options: Vestibular Migraine.

Authors:  Clinton G Lauritsen; Michael J Marmura
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

10.  A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.

Authors:  Joseph M Furman; Dawn A Marcus
Journal:  Int J Med Sci       Date:  2009-08-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.